ABEC has been investing in China for over ten years to support the rapid growth of China’s biotech industry, and pressure vessels are critical components of the systems used to manufacture biopharmaceuticals. The CML for Kells allows ABEC to provide fully-compliant systems from both the US and Europe, ensuring consistent and flexible supply to customers in China, as well as supporting foreign companies who are establishing manufacturing facilities in China.
“By earning the CML for Kells, ABEC continues to demonstrate our long-term commitment to customers in China,” said Scott Pickering, ABEC President and CEO. “We are proud of this achievement and our industry leadership in global code compliance for equipment manufacturing.”
Since 1974, ABEC has been a global leader in delivering integrated process solutions and services for manufacturing in the biopharmaceutical industry. A majority of the world's pharmaceutical and biotech companies are ABEC customers; with many of today's leading therapies manufactured by processes and equipment engineered, manufactured, installed and serviced by ABEC. Whether adding capacity or improving existing facilities, ABEC's turn-key solutions and support services reduce overall cost and time to market while delivering maximum productivity. To learn more about ABEC, visit, http://www.abec.com,http://www.abecsingleuse.com, email info@abec.com and follow us on LinkedIn.